These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9119355)

  • 41. Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.
    Abramson N; Lurie P; Mietlowski WL; Schilling A; Bennett JM; Horton J
    Cancer Treat Rep; 1982 Jun; 66(6):1273-7. PubMed ID: 7044535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination chemotherapy with MCNU, vindesine, melphalan, and prednisolone (MCNU-VMP therapy) in induction therapy for multiple myeloma. Japan Myeloma Study Group.
    Imamura Y; Takagi T; Yawata Y; Nishinarita S; Kosaka M; Mikuni C; Takatsuki K; Sezaki T; Mori M; Tsuchiya J
    Int J Hematol; 1994 Feb; 59(2):113-23. PubMed ID: 8018904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Radiotherapy for myeloma].
    Nagoshi H; Ide K; Suzuki H
    Nihon Rinsho; 1995 Mar; 53(3):653-7. PubMed ID: 7699900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improved long-term survival in multiple myeloma. Finnish Leukaemia Group.
    Eur J Haematol; 1989 Nov; 43(5):385-8. PubMed ID: 2612611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survival in multiple myeloma in Kerala.
    Nair MK; Varghese C; Krishnan E; Sankaranarayanan R; Nair B
    Natl Med J India; 1993; 6(1):7-10. PubMed ID: 8453369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Long-term survival in multiple myeloma].
    Sakalová A; Mikulecký M; Dedík L; Prümmerová M; Gazová S; Chabronová I; Mistrík M; Lipsic T
    Vnitr Lek; 1994 Feb; 40(2):98-103. PubMed ID: 8140770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population-based, single-center study with median follow-up of 13.7 years.
    Barzenje DA; Kolstad A; Ghanima W; Holte H
    Hematol Oncol; 2018 Feb; 36(1):217-223. PubMed ID: 28393375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Multiple myeloma].
    Kanoh T
    Rinsho Ketsueki; 1989 Aug; 30(8):1212-5. PubMed ID: 2601036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A case of solitary plasmacytoma that originated in a rib].
    Hihara J; Takeo S; Furuyama M; Saku M
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Mar; 41(3):456-60. PubMed ID: 8478576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Curability of solitary bone plasmacytoma.
    Dimopoulos MA; Goldstein J; Fuller L; Delasalle K; Alexanian R
    J Clin Oncol; 1992 Apr; 10(4):587-90. PubMed ID: 1548521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiotherapy in the treatment of solitary plasmacytoma.
    Jyothirmayi R; Gangadharan VP; Nair MK; Rajan B
    Br J Radiol; 1997 May; 70(833):511-6. PubMed ID: 9227234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Addition of a short course of chemotherapy did not improve outcome in patients with localized marginal B-cell lymphoma of the orbit.
    Avilés A; Neri N; Calva A; Huerta-Guzmán J; Cleto S; Nambo MJ
    Oncology; 2006; 70(3):173-6. PubMed ID: 16763405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple myeloma in Ethiopians: analysis of 22 cases.
    Shamebo M; Tekle-Haimanot R
    Ethiop Med J; 1992 Jul; 30(3):143-9. PubMed ID: 1396616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of plasmacytoma with hyperviscosity syndrome].
    Bosselmann HP; Gaede B; Franke A; Lachhein L
    Z Gesamte Inn Med; 1988 May; 43(10):271-3. PubMed ID: 3414142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Smoldering myeloma].
    Dolgos J; Patakfalvi A
    Orv Hetil; 1993 Sep; 134(39):2155-7. PubMed ID: 8414460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Solitary bone and extramedullary plasmacytoma.
    Weber DM
    Hematology Am Soc Hematol Educ Program; 2005; ():373-6. PubMed ID: 16304406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple myeloma: the National University Hospital (NUH) experience.
    Lim HL; Teo CP; Wong K; Kuperan P; Suri R; Tan YO; Kueh YK
    Singapore Med J; 1994 Aug; 35(4):371-3. PubMed ID: 7899894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Solitary plasmacytoma. A retrospective analysis of 15 cases].
    Avilés A; Díaz-Maqueo JC; García EL; Guzmán R; Talavera A
    Rev Invest Clin; 1990; 42(4):277-80. PubMed ID: 2091178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The role of radiotherapy in combined treatment of chondrosarcoma of the bone].
    Golbicić I; Sobić V; Jelić Lj; Sbutega B
    Srp Arh Celok Lek; 1991; 119(3-4):99-102. PubMed ID: 1796337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of definitive radiotherapy on the long-term outcome in patients with solitary extramedullary plasmacytoma.
    Skóra T; Pudełek K; Nowak-Sadzikowska J; Pietrasz M; Szyszka-Charewicz B; Jakubowicz J
    Hematol Oncol; 2017 Sep; 35(3):317-322. PubMed ID: 26450521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.